Please assess the completion status of the following clinical trial:

Trial Title: Ovulation Induction in Women With Clomiphene Citrate Resistant PCOS

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: EARLY_PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 20-40 years old~* PCOS infertile women resistant to CC for3 cycles~Exclusion Criteria:~* presence of medical disorders as diabetes, hypertension, cardiac problems, liver or kidney diseases, hyperprolactinemia or thyroid dysfunction.~* use of gonadotropins before~* previous ovarian drilling~* presence of urinary symptoms especially bloody urine

- Gender: FEMALE
- Minimum Age: 20 Years
- Maximum Age: 40 Years
- Healthy Volunteers: f

Study Arms:
- arm 1:letrozole-pioglitazone -metformin group (Type: ACTIVE_COMPARATOR): Arm 1 will receive letrozole 2.5 mg/day starting from the 3rd day of the cycle and for 5 days and (combined pioglitazone 15 mg+ metformin 850 mg) once daily from the first day of the cycle for 10 days.
- arm 2: clomiphene citrate-pioglitazone-metformin (Type: ACTIVE_COMPARATOR): Arm 2 will receive clomiphene citrate 100 mg/day starting from the 3rd day of the cycle for 5 days and (combined pioglitazone 15 mg + metformin 850 mg) once daily from the first day of the cycle for 10 days.

Based on this trial design, predict the completion outcome and termination type (if applicable).